Phase I Trial of 225Ac-J591 in Patients With mCRPC
NCT03276572
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
225Ac-J591
Sponsor
Weill Medical College of Cornell University
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]